Relationship of urinary isoprostanes to prostate cancer occurrence. - Wikidata - wikimedia - TriplyDB

Relationship of urinary isoprostanes to prostate cancer occurrence.

Relationship of urinary isoprostanes to prostate cancer occurrence.

http://www.wikidata.org/entity/Q42355379

about

Oxidative stress in prostate cancer patients: A systematic review of case control studies The isoprostanes--25 years later Thioredoxin 1 in Prostate Tissue Is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary Antioxidants.Esophageal squamous cell cancer in a highly endemic region.Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes.Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling.Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.Uric acid: a modulator of prostate cells and activin sensitivity.Intake of dietary antioxidants is inversely associated with biomarkers of oxidative stress among men with prostate cancer.Measurement of Serum and Hepatic Eicosanoids by Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS) in a Mouse Model of Hepatocellular Carcinoma (HCC) with Delivery of c-Met and Activated β-Catenin by Hepatocyte Hydrodynamic Injection.

P2860

Q28068523-0A6871F9-379F-4596-A898-9AC2914645D8 Q33601352-1AA76363-84BB-4AD6-A69C-635A806B85EA Q36016027-65DD4521-62EE-4089-B04B-488ADC1C6A05 Q36650819-87D02C8C-88BA-4402-8C61-8E3C571A34C3 Q36673532-932E0B26-AEF0-4645-8BBC-5617C6E298D6 Q37086148-9196499A-63DF-43AD-8F71-FC66EC49288E Q37741459-DB8513ED-9AA8-4EC3-BEA5-B357E6D26A73 Q38791408-BD8103A3-4753-4276-9F12-343AA4069DDB Q41161738-12E2E1F3-DB61-43BE-A364-F7C27C59BAD3 Q55003371-49317371-BE4A-450E-B1E9-C39B8D3D55F6

P2860

Relationship of urinary isoprostanes to prostate cancer occurrence.

http://www.wikidata.org/entity/Q42355379

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Relationship of urinary isoprostanes to prostate cancer occurrence.

@en

Relationship of urinary isoprostanes to prostate cancer occurrence.

@nl

type

label

Relationship of urinary isoprostanes to prostate cancer occurrence.

@en

Relationship of urinary isoprostanes to prostate cancer occurrence.

@nl

prefLabel

Relationship of urinary isoprostanes to prostate cancer occurrence.

@en

Relationship of urinary isoprostanes to prostate cancer occurrence.

@nl

P1433

Q42355379-E0C216B5-ED71-4908-ACA1-8E8D23BE077A

P1476

Q42355379-C967FFE8-E629-41D8-A17D-39404DA25F59

P2093

Q42355379-0F9BAF7E-9D8A-4F18-9ECD-6C38D2195C5D

Q42355379-5440B604-B83D-4480-A42E-F6998ABF3E1B

Q42355379-5F558B34-0988-4838-8778-D88908A3C281

Q42355379-A681D9EE-25A1-4DC2-8921-5A3B78136AE8

Q42355379-B0B4805B-8621-425F-91CF-93AC1D2356FF

Q42355379-BDA7D31F-1BF1-4B29-907B-EBF6CFA18A39

Q42355379-D16DB83F-2978-4521-8BDA-8C07869890A9

P2860

Q42355379-07D2E832-4404-47BC-AFAC-547AFE60494B

Q42355379-1F240350-37FF-430C-9E12-C25CE2D573E1

Q42355379-29032B39-5B4E-4A95-A8CF-0E62C7FF6759

Q42355379-29B9DE2E-21A1-440C-8E7B-F9B6E1CC511D

Q42355379-2F1B33A5-B87C-42AE-90E5-66A4225E6246

Q42355379-323565BA-2D41-4336-A24A-DE43DB6C6C04

Q42355379-46D42DED-5FEF-44A1-9EAA-1975EE27E773

Q42355379-48FD8E0E-4D97-44A0-9F7A-7FECBA5BDF2F

Q42355379-6A27D770-7369-4BA8-91BA-4261D9D14DBE

Q42355379-6C433B5E-0670-4ECC-AA41-6D8420879D53

P2888

Q42355379-9930540E-5C2F-4D99-94B0-E6F6F0BCC36D

P304

Q42355379-A8BCD4BE-15A3-494D-9581-7F4481E26E1A

P31

Q42355379-D0168C69-4321-4627-B648-CC4A718BC576

P356

Q42355379-ED1FB798-992F-4B57-AA66-C3633192FD4F

P433

Q42355379-4EEC4BD4-A99D-4F0B-A45C-BB9C9AAEFEB7

P478

Q42355379-7E50B5EE-51A1-4E7F-8E1A-99A13CA02A13

P577

Q42355379-37098B55-16FA-4BC9-B6D7-F38451198EC5

P5875

Q42355379-1DAAC5E4-5889-464E-A6EE-6A8AD058CE7A

P698

Q42355379-800ADE3C-18D9-43D9-9E97-7C16BD4335E3

P932

Q42355379-F883DE9E-A8C8-42E7-B0E4-D05088CB29AD

P356

S11010-012-1455-Z

P1433

Molecular and Cellular Biochemistry

P1476

Relationship of urinary isoprostanes to prostate cancer occurrence.

@en

P2093

Agnieszka Morel

http://www.w3.org/2001/XMLSchema#string

Anna Krzeslak

http://www.w3.org/2001/XMLSchema#string

Beata Olas

http://www.w3.org/2001/XMLSchema#string

Ewa Forma

http://www.w3.org/2001/XMLSchema#string

Jacek Wilkosz

http://www.w3.org/2001/XMLSchema#string

Magdalena Brys

http://www.w3.org/2001/XMLSchema#string

Waldemar Rozanski

http://www.w3.org/2001/XMLSchema#string

P2860

The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.

Antioxidants in health and disease.

Isoprostanes: markers and mediators of oxidative stress.

Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer

The isoprostanes: unique products of arachidonic acid oxidation-a review.

Determinants of F2-isoprostane biosynthesis and inhibition in man.

Isoprostanes: novel bioactive products of lipid peroxidation.

P2888

s11010-012-1455-z

P304

149-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-012-1455-Z

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230864373

http://www.w3.org/2001/XMLSchema#string

P698

22983829

http://www.w3.org/2001/XMLSchema#string

P932

3506833

http://www.w3.org/2001/XMLSchema#string